- Eskalace a deeskalace léčby pacientek s karcinomem prsu v roce 20212022 | First Faculty of Medicine
- Eskalace a deeskalace léčby u časného karcinomu prsu s HER2 pozitivitou2021 | First Faculty of Medicine
- Management of HER2-positive breast cancer, escalation and de-escalation of the therapy2017 | First Faculty of Medicine
- Personalization of neo/adjuvant treatment of HER2-positive breast cancer is the key to achieve the best results2022 | First Faculty of Medicine
- Neoadjuvant treatment of HER2-positive breast cance2023 | First Faculty of Medicine
- Predictive markers in breast cancer2021 | First Faculty of Medicine
- Treatment of HER2-positive breast cancer in 20202020 | First Faculty of Medicine